Chwee Teck Lim's Biography

Chwee Teck Lim, NUS Society Chair Professor, Department of Biomedical Engineering, Institute for Health Innovation & Technology (iHealthtech), Mechanobiology Institute, National University of Singapore

Professor Chwee Teck LIM is the NUSS Chair Professor and Director of the Institute for Health Innovation and Technology at the National University of Singapore. He has coauthored over 500 journal publications and cofounded six startups with one public listed in 2018. Prof Lim is an elected Fellow of nine academies and organizations including the Royal Society UK, US National Academy of Inventors, IUPESM, AIMBE, IAMBE, Singapore National Academy of Science and Academy of Engineering Singapore. He has garnered numerous research awards including Nature Lifetime Achievement Award for Mentoring in Science, Highly Cited Researcher, Asia’s Most Influential Scientist Award, Wall Street Journal Asian Innovation Award (Gold) and the President's Technology Award.

Microfluidic Approaches to Isolating Micro- and Nanoscale Circulating Biomarkers for Cancer Diagnosis and Monitoring

Thursday, 5 October 2023 at 10:15

Add to Calendar ▼2023-10-05 10:15:002023-10-05 11:15:00Europe/LondonMicrofluidic Approaches to Isolating Micro- and Nanoscale Circulating Biomarkers for Cancer Diagnosis and MonitoringLab-on-a-Chip and Microfluidics Asia 2023 in Tokyo, JapanTokyo, JapanSELECTBIOenquiries@selectbiosciences.com

Microfluidics has emerged as a powerful technology not only for biological but also clinical research and applications. For example, the ability to manipulate and analyse minute volume of fluids and samples has led to a wealth of new biological assays which can provide unique approaches for better manipulation and capture of micro- and even nanoscale circulating biomarkers such as cells, extracellular vesicles and exosomes. With these new tools, researchers are not only being led to new questions and discoveries, but also applications in disease diagnosis, monitoring and even therapy. Here, I will present several microfluidic technologies that we have developed for both biological and clinical applications relating to diseases such as cancer. These includes microfluidic chips for rare diseased cell separation and culture as well as capture of extracellular vesicles and exosomes.

Add to Calendar ▼2023-10-05 00:00:002023-10-06 00:00:00Europe/LondonLab-on-a-Chip and Microfluidics Asia 2023Lab-on-a-Chip and Microfluidics Asia 2023 in Tokyo, JapanTokyo, JapanSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors